Inhaled corticosteroids increase the risk of oropharyngeal colonization by Streptococcus pneumoniae in children with asthma

Respirology

Volumn 18, Issue 2, 2013, Pages 272-277

  Zhang, Linjie ^a   Prietsch, Sílvio O M ^a   Mendes, Ana Paula ^b   Von Groll, Andrea ^b   Rocha, Gicelle Porto ^a   Carrion, Lillian ^a   Da Silva, Pedro Eduardo Almeida ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^b University of Anhanguera   (Brazil)

Author keywords

asthma; cross sectional study; inhaled corticosteroid; oropharyngeal colonization; Streptococcus pneumoniae

Indexed keywords

BECLOMETASONE; BUDESONIDE PLUS FORMOTEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BACTERIAL COLONIZATION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; STREPTOCOCCUS PNEUMONIAE; TONSIL; TREATMENT DURATION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ASTHMA; BECLOMETHASONE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; OROPHARYNX; PNEUMOCOCCAL INFECTIONS; PREVALENCE; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 84872945862     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02280.x     Document Type: Article

References (21)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2009 (Update). [Accessed: 5 Aug 2011.] Available from URL: http://www.ginasthma.org
2. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Revised in May 2011. [Accessed: 5 Aug 2011.] Available from URL: http://www.brit-thoracic.org.uk/guidelines/ asthma-guidelines.aspx
3. Qaseem A, Snow V, Shekelle P, et al,. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Diagnosis and management of stable chronic obstructive pulmonary disease: A clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 2007; 147: 633-8. (Pubitemid 351664484)
4. Barnes PJ, Pedersen S, Busse WW,. Efficacy and safety of inhaled corticosteroids: new developments. Am. J. Respir. Crit. Care Med. 1998; 157 (3 Pt 2): S1-S53. (Pubitemid 28125600)
5. Allen DB,. Safety of inhaled corticosteroids in children. Pediatr. Pulmonol. 2002; 33: 208-20. (Pubitemid 34175049)
6. Singh S, Amin AV, Loke YK,. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease. A meta-analysis. Arch. Intern. Med. 2009; 169: 219-29.
7. Drummond MB, Dasenbrrok EC, Pitz MW, et al,. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. JAMA 2008; 300: 2407-16.
8. O'Byrne PM, Pedersen S, Carlsson L, et al,. Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 2011; 183: 589-95.
9. Fukushima C, Matsuse H, Saeki S, et al,. Salivary IgA and oral Candidiasis in asthmatic patients treated with inhaled corticosteroid. J. Asthma 2005; 42: 601-4. (Pubitemid 41765313)
10. Bateman ED, Hurd SS, Barnes PJ, et al,. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 2008; 31: 143-78.
11. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Test; Approved Standard-8th Edition. NCCLS Document M2-A8. The Institute, Wayne, PA, 2003.
12. Bogaert D, de Groot R, Hermans PWM,. Streptococcus pneumoniae colonization: the key to pneumococcal disease. Lancet Infect. Dis. 2004; 4: 144-54. (Pubitemid 38293138)
13. Hakansson A, Carlstedt I, Davies J, et al,. Aspects on the interaction of Streptococcus pneumoniae and Haemophilus influenzae with human respiratory tract mucosa. Am. J. Respir. Crit. Care Med. 1996; 154 (4 Pt2): S187-9.
14. García-Rodríguez JA, Martinez MJF,. Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J. Antimicrob. Chemother. 2002; 50 (Suppl. S2): 59-73. (Pubitemid 36175839)
15. Jounio U, Juvonen R, Bloigu A, et al,. Pneumococcal carriage is more common in asthmatic than in non-asthmatic young men. Clin. Respir. J. 2010; 4: 222-9.
16. Talbot TR, Hartert TV, Mitchel E, et al,. Asthma as a risk factor for invasive pneumococcal disease. N. Engl. J. Med. 2005; 352: 2082-90. (Pubitemid 40667531)
17. Marrie TJ,. Pneumococcal pneumonia: epidemiology and clinical features. Semin. Respir. Infect. 1999; 14: 227-36. (Pubitemid 29444890)
18. Baquero F, Baquero-Artigao G, Cantõn R, et al,. Antibiotic consumption and resistance selection in Streptococcus pneumoniae. J. Antimicrob. Chemother. 2002; 50 (Suppl. S2): 27-37. (Pubitemid 36175835)
19. Albrich WC, Monnet DL, Harbarth S,. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg. Infect. Dis. 2004; 10: 514-7. (Pubitemid 38314485)
20. Lieberman D, Shleyfer E, Castel H, et al,. Nasopharyngeal versus oropharyngeal sampling for isolation of potential respiratory pathogens in adults. J. Clin. Microbiol. 2006; 44: 525-58.
21. D'Avila NE, Zhang L, Miller RG, et al,. High prevalence of nasopharyngeal colonization by Staphylococcus aureus among children with HIV-1 infection in extreme southern Brazil. J. Trop. Pediatr. 2008; 54: 410-2.